Appointment of Narendra Rajput as Internal Auditor for FY 25-26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has re-appointed M/s NP Rajput & Co as its Internal Auditor for the financial year 2025-26. The decision was taken by the Board of Directors on 14th May 2025, based on the recommendation of the Audit Committee. NP Rajput & Co is a firm with experience in income tax, GST, accounting, internal audit, and GST audit assignments. This is a continuation of their existing role as internal auditor for the company. The disclosure has been made to BSE under SEBI listing regulations.
This is a routine, procedural re-appointment and is unlikely to have any material impact on the stock price or shareholder value. It reflects continuity in internal audit and compliance processes.